Discover how the latest advances in genomics can help identify important mutations in cancer. http://www.illumina.com/applications/cancer/clinical-cancer-research.html Dr.Rossi and his lab at the Winship Cancer Institute have been at the forefront of next generation sequencing (NGS) and microarray technology development for cancer diagnostics and research. Dr.Rossi describes the value of molecular testing, including the benefits of multi-analyte vs. single-analyte testing, and how labs can implement NGS assays for clinical research using existing technologies. Specific examples of established processes for oncology research, using archival (FFPE) tissues, and the basics of workflow, reporting and interpretation will be discussed. A great resource for newcomers to NGS, and those looking to explore targeted sequencing applications. Presenter: Michael R. Rossi, PhD, FACMG Assistant Professor, Department of Pathology and Laboratory Medicine Emory University School of Medicine https://winshipcancer.emory.edu/bios/faculty/rossi-michael.html Subscribe to the Illumina video channel. http://www.youtube.com/subscription_center?add_user=IlluminaInc